C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1997
12/02/1997	US5693530 Recombinant vectors; vaccines
12/02/1997	US5693522 Anti-cancer immunotherapeutics
12/02/1997	US5693516 Mixing with a surfactant and a water immiscible organic solvent to form a reverse micelle solution; evaporation to dryness
12/02/1997	US5693515 Metal complexed serine protease inhibitors
12/02/1997	US5693511 Immortalized human fetal osteoblastic cells
12/02/1997	US5693508 Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
12/02/1997	US5693502 Nucleic acid ligand inhibitors to DNA polymerases
12/02/1997	US5693501 Compounds and methods to determine presence of Histoplasma capsulatum
12/02/1997	US5693500 Using a dna probe corresponding to all or a portion of the m. bovis dna antigen; test kits; sensitivity
12/02/1997	US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression
12/02/1997	US5693498 DNA encoding a plerocerciod growth factor
12/02/1997	US5693497 Incubation of genetically engineered cells for gene expression of antigen which can be used for vaccines or diagnosis
12/02/1997	US5693496 DNA encoding the mouse and human PH30 beta chain protein
12/02/1997	US5693495 Allergens of alder pollen and applications thereof
12/02/1997	US5693493 Modular assembly of antibody genes, antibodies prepared thereby and use
12/02/1997	US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel
12/02/1997	US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence
12/02/1997	US5693487 Diagnostic or prognostic indicator for diverse types of cancer determined by changes in the levels of max:myc complex that binds to nucleotide sequences comprising cacgtg
12/02/1997	US5693481 Identifying melanoma cells that produce protein inhibitor of cytokine activity by culturing said cells, assaying medium for protein inhibitor
12/02/1997	US5693478 Method of detecting amyloid precursor proteins
12/02/1997	US5693477 Receptor membranes
12/02/1997	US5693473 Linked breast and ovarian cancer susceptibility gene
12/02/1997	US5693472 Detecting dna of seq id no:1,2,3 or 4 by hybridization probing and/or nucleotide sequence amplification; testing samples of surface water or feces; vaccines
12/02/1997	US5693470 Determining predisposition to hereditary non-polyposis colorectal cancer by testing cell samples for a mutant gene which affects expression of a protein indicator
12/02/1997	US5693465 Determining risk of metastasis by determining whether tissue sample expresses polypeptide containing amino acid sequence designated pliv1
12/02/1997	US5693463 Measuring amount of protein bound to double-stranded dna test oligonucleotide before and after incubation, repeating with different test sequences, comparison for rank order
12/02/1997	US5693343 Mixing acetonitrile solutions of antigen-sucrose matrix and glycolide-lactide copolymer, then emulsification with an oil and centrifuging yields microspheres containing encapsulated antigen for orally administered vaccines
12/02/1997	US5693325 Peptide vaccines and methods relating thereto
11/1997
11/30/1997	CA2206575A1 Live attenuated rtx-producing bacteria of the family pasteurellaceae
11/29/1997	CA2187728A1 Iron-regulated metal transporters and uses therefor
11/27/1997	WO1997044667A2 Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
11/27/1997	WO1997044493A1 Anti-paramyxovirus screening method and vaccine
11/27/1997	WO1997044490A1 Specific co-activator for human androgen receptor
11/27/1997	WO1997044487A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/27/1997	WO1997044481A1 Compositions and methods for screening antimicrobials
11/27/1997	WO1997044475A1 Adenovirus vectors for gene therapy
11/27/1997	WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997	WO1997044470A1 Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
11/27/1997	WO1997044469A2 Multiple epitope fusion protein
11/27/1997	WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997	WO1997044464A1 Helicobacter pylori acid inhibitory factor 1
11/27/1997	WO1997044463A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
11/27/1997	WO1997044462A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044459A1 Gamma ii adaptin
11/27/1997	WO1997044458A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda
11/27/1997	WO1997044457A1 Polycystic kidney disease gene
11/27/1997	WO1997044456A2 Tumor virus susceptibility genes and gene products, and uses related thereto
11/27/1997	WO1997044455A1 Hematopoietic cytokine receptor
11/27/1997	WO1997044454A2 Human phospholipase inhibitor
11/27/1997	WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	WO1997044452A1 Human b-cell antigens, related reagents
11/27/1997	WO1997044451A2 Vasoactive amine binding molecules
11/27/1997	WO1997044449A1 Promoters for swine complement inhibitors
11/27/1997	WO1997044447A2 Transcriptional activation system, activators, and uses therefor
11/27/1997	WO1997044446A1 Dna vaccines for eliciting a mucosal immune response
11/27/1997	WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997	WO1997044440A1 Cell line
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044358A1 Zona pellucida proteins for contraception
11/27/1997	WO1997044357A1 Synthetic glucagon binding proteins
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044355A1 Biological insect control agent
11/27/1997	WO1997044354A2 Synthesis of soluble beta-sheet forming peptides
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044351A1 Immunomodulating dimers
11/27/1997	WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
11/27/1997	WO1997044347A1 Human cis protein
11/27/1997	WO1997044061A1 Aspergillus fumigatus lectin and methods of using same
11/27/1997	WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997	WO1997044055A1 Methods of identifying g-coupled receptors associated with macrophage-trophic hiv, and diagnostic and therapeutic uses thereof
11/27/1997	WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	WO1997044050A1 Human calcium sensor protein, fragments thereof and dna encoding same
11/27/1997	WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997	WO1997039102A3 Secreted proteins
11/27/1997	WO1997035976A3 Epidermal differentiation factor
11/27/1997	WO1997031111A3 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them
11/27/1997	WO1997031107A3 Human serum lectin - induced apoptosis and method for detecting apoptosis
11/27/1997	WO1997024974A3 Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	DE19622289A1 Zona Pellucida Proteine zur Kontrazeption Zona pellucida proteins for contraception
11/27/1997	CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997	CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	CA2256465A1 Blocking expression of virulence factors in s. aureus
11/27/1997	CA2256338A1 Zona pellucida proteins for contraception
11/27/1997	CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997	CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255706A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/27/1997	CA2255572A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997	CA2255541A1 Synthetic glucagon binding proteins
11/27/1997	CA2254843A1 Human b-cell antigens, related reagents
11/27/1997	CA2254083A1 Polycystic kidney disease gene
11/27/1997	CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997	CA2253541A1 Human phospholipase inhibitor
11/27/1997	CA2253431A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda

1 ... 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 ... 2916